Back

HLA-A*02:01 allele is associated with decreased risk and a longer survival in pancreatic cancer: Results from an exhaustive analysis of the HLA variation in PDAC

Langtry, A.; Rabadan, R.; Alonso, L.; van Eijck, C.; Macarulla, T.; Lawlor, R.; Carrato, A.; Alvarez-Gallego, R.; Iglesias, M.; Molero, X.; Lohr, J. M.; Michalski, C.; Perea, J.; ORorke, M.; Barber, V.; Tardon, A.; Farre, A.; Munoz-Bellvis, L.; Crnogorac-Jurcevic, T.; Dominguez-Munoz, E.; Gress, T.; Greenhalf, W.; Sharp, L.; Sabroso-Lasa, S.; Filip, I.; Strijk, G.; Castet, F.; Balsells, J.; Costello, E.; Kleeff, J.; Kong, B.; Mora, J.; ODriscoll, D.; Scarpa, A.; Ye, W.; Real, F. X.; Malats, N.; Lopez de Maturana, E.

2024-08-29 oncology
10.1101/2024.08.29.24312704 medRxiv
Show abstract

Genetic susceptibility loci are associated with PDAC risk and survival, but the impact of germline HLA region variation remains largely unexplored. This study examined HLA I-II alleles within the PanGenEU study and validated our findings using external datasets (UK Biobank, TCGA, PAN-NGS trial, and Caris trial). HLA-A*02:01and HLA-B*49 alleles were linked to a decreased risk of PDAC, whereas HLA-B*39, HLA-DPB1*04, and HLA-A*26:01 were directly associated with increased risk. PDAC patients carrying the HLA-A*02:01 allele also showed lower mortality rates, with the effect being more pronounced in those with KRASG12V mutations, pointing to a host*tumor genetic interaction. This research highlights HLA-A*02:01, found in 20% of Europeans, as a marker for reduced PDAC risk and mortality, especially in KRASG12V mutated tumors. Results from this study could enhance personalized medicine for PDAC by identifying patients who may benefit from regular screenings through tailored risk assessments. Importantly, our findings are crucial for stratifying PDAC patients based on their genetic background and tumor mutational profile, which can guide treatment strategies.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.